KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Non-Current Deffered Revenue (2016 - 2026)

Chemed filings provide 18 years of Non-Current Deffered Revenue readings, the most recent being $142.7 million for Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deffered Revenue rose 12.07% year-over-year to $142.7 million, compared with a TTM value of $142.7 million through Mar 2026, up 12.07%, and an annual FY2025 reading of $136.1 million, up 8.02% over the prior year.
  • Non-Current Deffered Revenue hit $142.7 million in Q1 2026 for Chemed, up from $136.1 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $142.7 million in Q1 2026, with the low at $89.9 million in Q3 2022.
  • Median Non-Current Deffered Revenue over the past 5 years was $117.6 million (2024), compared with a mean of $113.7 million.
  • The sharpest move saw Non-Current Deffered Revenue decreased 10.49% in 2022, then grew 21.11% in 2024.
  • Year by year, Non-Current Deffered Revenue stood at $92.3 million in 2022, then grew by 12.71% to $104.1 million in 2023, then grew by 21.11% to $126.0 million in 2024, then grew by 8.02% to $136.1 million in 2025, then grew by 4.79% to $142.7 million in 2026.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $142.7 million, $136.1 million, and $132.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.